High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors
Elisabetta Falvo(Institute of Molecular Biology and Pathology), Pierpaolo Ceci(Institute of Molecular Biology and Pathology)
Cited by 26